Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aquestive Therapeutics Inc AQST

Healthcare
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on... see more

Recent & Breaking News (NDAQ:AQST)

Aquestive Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

GlobeNewswire August 6, 2019

Aquestive Therapeutics Announces Positive Topline Results from Libervantâ„¢ (Diazepam) Buccal Film Single Dose Crossover Study

GlobeNewswire August 6, 2019

Aquestive Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference

GlobeNewswire July 29, 2019

Aquestive Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Business Highlights on August 7, 2019

PR Newswire July 18, 2019

Aquestive Therapeutics Completes $70 Million Debt Refinancing

PR Newswire July 15, 2019

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

PR Newswire June 7, 2019

Aquestive Therapeutics Completes Enrollment in Libervant(TM) (diazepam buccal film) Crossover Study

PR Newswire June 4, 2019

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

PR Newswire May 13, 2019

IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil

GlobeNewswire May 8, 2019

Aquestive Therapeutics Reports First Quarter 2019 Financial Results and Recent Business Highlights

PR Newswire May 8, 2019

Aquestive Therapeutics Announces Daniel Barber Named to Chief Operating Officer

PR Newswire May 7, 2019

Aquestive Therapeutics to Announce First Quarter 2019 Financial Results and Recent Business Highlights on May 8, 2019

PR Newswire April 17, 2019

Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application for Riluzole Oral Film for Treatment of ALS

PR Newswire April 16, 2019

Aquestive Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

PR Newswire March 25, 2019

Aquestive Therapeutics, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights

PR Newswire March 14, 2019

Aquestive Therapeutics to Present at Oppenheimer's 29th Annual Healthcare Conference

PR Newswire March 7, 2019

Aquestive Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights on March 14, 2019

PR Newswire February 19, 2019

Aquestive Therapeutics to Present at 2019 BIO CEO & Investor Conference

PR Newswire February 8, 2019

Aquestive Therapeutics Provides Update Regarding Suboxone® Sublingual Film Litigation

PR Newswire February 5, 2019

Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application

PR Newswire January 31, 2019